ID   GLSK_MOUSE              Reviewed;         674 AA.
AC   D3Z7P3; E9PUF0; Q69ZX9;
DT   13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   07-APR-2021, entry version 92.
DE   RecName: Full=Glutaminase kidney isoform, mitochondrial;
DE            Short=GLS;
DE            EC=3.5.1.2 {ECO:0000269|PubMed:22228304, ECO:0000269|PubMed:23935106, ECO:0000269|PubMed:27542409};
DE   Contains:
DE     RecName: Full=Glutaminase kidney isoform, mitochondrial 68 kDa chain {ECO:0000250|UniProtKB:P13264};
DE   Contains:
DE     RecName: Full=Glutaminase kidney isoform, mitochondrial 65 kDa chain {ECO:0000250|UniProtKB:P13264};
DE   Flags: Precursor;
GN   Name=Gls; Synonyms=Gls1, Kiaa0838;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryonic tail;
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING.
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   INTERACTION WITH ATCAY.
RX   PubMed=16899818; DOI=10.1242/jcs.03061;
RA   Buschdorf J.P., Li Chew L., Zhang B., Cao Q., Liang F.Y., Liou Y.C.,
RA   Zhou Y.T., Low B.C.;
RT   "Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to
RT   neurite terminals and reduces glutamate levels.";
RL   J. Cell Sci. 119:3337-3350(2006).
RN   [4]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16641247; DOI=10.1523/jneurosci.4241-05.2006;
RA   Masson J., Darmon M., Conjard A., Chuhma N., Ropert N., Thoby-Brisson M.,
RA   Foutz A.S., Parrot S., Miller G.M., Jorisch R., Polan J., Hamon M., Hen R.,
RA   Rayport S.;
RT   "Mice lacking brain/kidney phosphate-activated glutaminase have impaired
RT   glutamatergic synaptic transmission, altered breathing, disorganized goal-
RT   directed behavior and die shortly after birth.";
RL   J. Neurosci. 26:4660-4671(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   FUNCTION.
RX   PubMed=22373647; DOI=10.1038/jcbfm.2012.22;
RA   El Hage M., Masson J., Conjard-Duplany A., Ferrier B., Baverel G.,
RA   Martin G.;
RT   "Brain slices from glutaminase-deficient mice metabolize less glutamine: a
RT   cellular metabolomic study with carbon 13 NMR.";
RL   J. Cereb. Blood Flow Metab. 32:816-824(2012).
RN   [7]
RP   SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-135 AND LYS-169, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [8] {ECO:0007744|PDB:3SS3, ECO:0007744|PDB:3SS4, ECO:0007744|PDB:3SS5}
RP   X-RAY CRYSTALLOGRAPHY (2.42 ANGSTROMS) OF 128-555 (ISOFORM 2) IN COMPLEX
RP   WITH GLUTAMATE AND PHOSPHATE, FUNCTION, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, ALTERNATIVE SPLICING, MUTAGENESIS OF PHE-394, AND SUBUNIT.
RX   PubMed=22228304; DOI=10.1073/pnas.1112495109;
RA   Cassago A., Ferreira A.P., Ferreira I.M., Fornezari C., Gomes E.R.,
RA   Greene K.S., Pereira H.M., Garratt R.C., Dias S.M., Ambrosio A.L.;
RT   "Mitochondrial localization and structure-based phosphate activation
RT   mechanism of glutaminase C with implications for cancer metabolism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:1092-1097(2012).
RN   [9] {ECO:0007744|PDB:4JKT}
RP   X-RAY CRYSTALLOGRAPHY (2.77 ANGSTROMS) OF 128-555, SUBUNIT, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, AND MUTAGENESIS OF LYS-202; LYS-207 AND
RP   LYS-325.
RX   PubMed=23935106; DOI=10.1074/jbc.m113.501346;
RA   Ferreira A.P., Cassago A., Goncalves Kde A., Dias M.M., Adamoski D.,
RA   Ascencao C.F., Honorato R.V., de Oliveira J.F., Ferreira I.M.,
RA   Fornezari C., Bettini J., Oliveira P.S., Paes Leme A.F., Portugal R.V.,
RA   Ambrosio A.L., Dias S.M.;
RT   "Active glutaminase C self-assembles into a supratetrameric oligomer that
RT   can be disrupted by an allosteric inhibitor.";
RL   J. Biol. Chem. 288:28009-28020(2013).
RN   [10] {ECO:0007744|PDB:5W2J}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 141-551 OF MUTANT LYS-391,
RP   SUBUNIT, CATALYTIC ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR LOCATION,
RP   DOMAIN, AND MUTAGENESIS OF LYS-316; GLY-320; LYS-325 AND ASP-391.
RX   PubMed=27542409; DOI=10.1074/jbc.m116.720268;
RA   Li Y., Erickson J.W., Stalnecker C.A., Katt W.P., Huang Q., Cerione R.A.,
RA   Ramachandran S.;
RT   "Mechanistic basis of glutaminase activation: a key enzyme that promotes
RT   glutamine metabolism in cancer cells.";
RL   J. Biol. Chem. 291:20900-20910(2016).
CC   -!- FUNCTION: Catalyzes the first reaction in the primary pathway for the
CC       renal catabolism of glutamine. Plays a role in maintaining acid-base
CC       homeostasis. Regulates the levels of the neurotransmitter glutamate,
CC       the main excitatory neurotransmitter in the brain.
CC       {ECO:0000269|PubMed:16641247, ECO:0000269|PubMed:22228304,
CC       ECO:0000269|PubMed:22373647}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-glutamine = L-glutamate + NH4(+);
CC         Xref=Rhea:RHEA:15889, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:58359; EC=3.5.1.2;
CC         Evidence={ECO:0000269|PubMed:22228304, ECO:0000269|PubMed:23935106,
CC         ECO:0000269|PubMed:27542409};
CC   -!- ACTIVITY REGULATION: Isoform 1 and isoform 2 are activated by
CC       phosphate, due to increased affinity for glutamine (PubMed:22228304,
CC       PubMed:23935106, PubMed:27542409). At phosphate concentrations above 10
CC       mM, isoform 2 is more efficient than isoform 1.
CC       {ECO:0000269|PubMed:22228304, ECO:0000269|PubMed:23935106,
CC       ECO:0000269|PubMed:27542409}.
CC   -!- SUBUNIT: Homotetramer, dimer of dimers (PubMed:22228304,
CC       PubMed:27542409). The tetramers can assemble into rod-like oligomers
CC       (in vitro), but the physiological significance of this is not clear
CC       (PubMed:23935106). Interacts with RAF1 and MAP2K2 (By similarity).
CC       Interacts with ATCAY; the interaction is direct and may control GLS
CC       localization, negatively regulating its activity (PubMed:16899818).
CC       {ECO:0000250|UniProtKB:O94925, ECO:0000269|PubMed:16899818,
CC       ECO:0000269|PubMed:22228304, ECO:0000269|PubMed:23935106,
CC       ECO:0000269|PubMed:27542409}.
CC   -!- INTERACTION:
CC       D3Z7P3-2; D3Z7P3-2: Gls; NbExp=3; IntAct=EBI-15962029, EBI-15962029;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion
CC       {ECO:0000250|UniProtKB:P13264}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P13264}. Note=The 74-kDa cytosolic precursor is
CC       translocated into the mitochondria and processed via a 72-kDa
CC       intermediate to yield the mature 68- and 65-kDa subunits.
CC       {ECO:0000250|UniProtKB:P13264}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Mitochondrion
CC       {ECO:0000269|PubMed:16641247, ECO:0000269|PubMed:27542409}.
CC   -!- SUBCELLULAR LOCATION: [Glutaminase kidney isoform, mitochondrial 68 kDa
CC       chain]: Mitochondrion matrix {ECO:0000250|UniProtKB:P13264}.
CC       Note=Produced by the proteolytic processing of the 74-kDa cytosolic
CC       precursor. {ECO:0000250|UniProtKB:P13264}.
CC   -!- SUBCELLULAR LOCATION: [Glutaminase kidney isoform, mitochondrial 65 kDa
CC       chain]: Mitochondrion matrix {ECO:0000250|UniProtKB:P13264}.
CC       Note=Produced by the proteolytic processing of the 74-kDa cytosolic
CC       precursor. {ECO:0000250|UniProtKB:P13264}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=KGA {ECO:0000303|PubMed:22228304};
CC         IsoId=D3Z7P3-1; Sequence=Displayed;
CC       Name=2; Synonyms=Glutaminase C {ECO:0000303|PubMed:23935106}, GAC
CC       {ECO:0000303|PubMed:22228304, ECO:0000303|PubMed:23935106};
CC         IsoId=D3Z7P3-2; Sequence=VSP_043804;
CC   -!- DOMAIN: A highly mobile activation loop at the dimer-dimer interface is
CC       important for enzyme activity. {ECO:0000269|PubMed:27542409}.
CC   -!- DOMAIN: The C-terminal ANK repeats prevent the assembly of the supra-
CC       tetrameric filaments. {ECO:0000250|UniProtKB:O94925}.
CC   -!- PTM: Synthesized as a 74-kDa cytosolic precursor which is
CC       proteolytically processed by the mitochondrial-processing peptidase
CC       (MPP) via a 72-kDa intermediate to yield the mature mitochondrial
CC       68- and 65-kDa subunits. {ECO:0000250|UniProtKB:P13264}.
CC   -!- DISRUPTION PHENOTYPE: Death during the first days after birth. Pups
CC       appear normal and display normal levels of activity, but their activity
CC       is disorganized. Pups do not orient to the dam, do not succeed in
CC       grasping a nipple and do not feed properly. In addition, they display
CC       altered respiration. {ECO:0000269|PubMed:16641247}.
CC   -!- SIMILARITY: Belongs to the glutaminase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD32317.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK173039; BAD32317.1; ALT_INIT; mRNA.
DR   EMBL; AC123752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS35561.1; -. [D3Z7P3-1]
DR   CCDS; CCDS48256.1; -. [D3Z7P3-2]
DR   RefSeq; NP_001074550.1; NM_001081081.2. [D3Z7P3-1]
DR   RefSeq; NP_001106854.1; NM_001113383.1. [D3Z7P3-2]
DR   PDB; 3SS3; X-ray; 2.42 A; A/B/C/D=128-602.
DR   PDB; 3SS4; X-ray; 2.85 A; A/B/C/D=128-602.
DR   PDB; 3SS5; X-ray; 2.80 A; A/B/C/D=128-602.
DR   PDB; 4JKT; X-ray; 2.77 A; A/B/C/D=128-555.
DR   PDB; 5W2J; X-ray; 2.50 A; A/B=141-551.
DR   PDBsum; 3SS3; -.
DR   PDBsum; 3SS4; -.
DR   PDBsum; 3SS5; -.
DR   PDBsum; 4JKT; -.
DR   PDBsum; 5W2J; -.
DR   SMR; D3Z7P3; -.
DR   BioGRID; 199955; 10.
DR   DIP; DIP-60006N; -.
DR   IntAct; D3Z7P3; 1.
DR   STRING; 10090.ENSMUSP00000110158; -.
DR   iPTMnet; D3Z7P3; -.
DR   PhosphoSitePlus; D3Z7P3; -.
DR   SwissPalm; D3Z7P3; -.
DR   EPD; D3Z7P3; -.
DR   jPOST; D3Z7P3; -.
DR   MaxQB; D3Z7P3; -.
DR   PaxDb; D3Z7P3; -.
DR   PeptideAtlas; D3Z7P3; -.
DR   PRIDE; D3Z7P3; -.
DR   ProteomicsDB; 271395; -. [D3Z7P3-1]
DR   ProteomicsDB; 271396; -. [D3Z7P3-2]
DR   Antibodypedia; 34041; 427 antibodies.
DR   Ensembl; ENSMUST00000114510; ENSMUSP00000110155; ENSMUSG00000026103. [D3Z7P3-2]
DR   Ensembl; ENSMUST00000114513; ENSMUSP00000110158; ENSMUSG00000026103. [D3Z7P3-1]
DR   GeneID; 14660; -.
DR   KEGG; mmu:14660; -.
DR   UCSC; uc007aye.2; mouse. [D3Z7P3-1]
DR   UCSC; uc011wko.1; mouse. [D3Z7P3-2]
DR   CTD; 2744; -.
DR   MGI; MGI:95752; Gls.
DR   eggNOG; KOG0506; Eukaryota.
DR   GeneTree; ENSGT00390000010463; -.
DR   HOGENOM; CLU_016439_1_1_1; -.
DR   InParanoid; D3Z7P3; -.
DR   OrthoDB; 349094at2759; -.
DR   TreeFam; TF313359; -.
DR   Reactome; R-MMU-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-MMU-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-MMU-8964539; Glutamate and glutamine metabolism.
DR   BioGRID-ORCS; 14660; 11 hits in 52 CRISPR screens.
DR   ChiTaRS; Gls; mouse.
DR   PRO; PR:D3Z7P3; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; D3Z7P3; protein.
DR   Bgee; ENSMUSG00000026103; Expressed in brain and 275 other tissues.
DR   Genevisible; D3Z7P3; MM.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISO:MGI.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0004359; F:glutaminase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:MGI.
DR   GO; GO:0006537; P:glutamate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0090461; P:glutamate homeostasis; ISO:MGI.
DR   GO; GO:0006543; P:glutamine catabolic process; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; IMP:MGI.
DR   GO; GO:0001967; P:suckling behavior; IMP:MGI.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 3.40.710.10; -; 1.
DR   HAMAP; MF_00313; Glutaminase; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR012338; Beta-lactam/transpept-like.
DR   InterPro; IPR015868; Glutaminase.
DR   InterPro; IPR041541; Glutaminase_EF-hand.
DR   PANTHER; PTHR12544; PTHR12544; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF17959; EF-hand_14; 1.
DR   Pfam; PF04960; Glutaminase; 1.
DR   SMART; SM00248; ANK; 2.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56601; SSF56601; 1.
DR   TIGRFAMs; TIGR03814; Gln_ase; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ANK repeat; Cytoplasm;
KW   Hydrolase; Mitochondrion; Phosphoprotein; Reference proteome; Repeat;
KW   Transit peptide.
FT   TRANSIT         1..54
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           55..674
FT                   /note="Glutaminase kidney isoform, mitochondrial 68 kDa
FT                   chain"
FT                   /id="PRO_0000417583"
FT   CHAIN           73..674
FT                   /note="Glutaminase kidney isoform, mitochondrial 65 kDa
FT                   chain"
FT                   /evidence="ECO:0000250|UniProtKB:P13264"
FT                   /id="PRO_0000447413"
FT   REPEAT          590..619
FT                   /note="ANK 1"
FT   REPEAT          624..653
FT                   /note="ANK 2"
FT   REGION          320..327
FT                   /note="Highly mobile activation loop"
FT                   /evidence="ECO:0000269|PubMed:27542409"
FT   COMPBIAS        59..62
FT                   /note="Poly-Gly"
FT   COMPBIAS        91..99
FT                   /note="Poly-Gln"
FT   BINDING         291
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22228304,
FT                   ECO:0007744|PDB:3SS5"
FT   BINDING         340
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22228304,
FT                   ECO:0007744|PDB:3SS5"
FT   BINDING         386
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22228304,
FT                   ECO:0007744|PDB:3SS5"
FT   BINDING         393
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22228304,
FT                   ECO:0007744|PDB:3SS5"
FT   BINDING         419
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22228304,
FT                   ECO:0007744|PDB:3SS5"
FT   BINDING         471
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:22228304,
FT                   ECO:0007744|PDB:3SS5"
FT   BINDING         489
FT                   /note="Substrate; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:22228304,
FT                   ECO:0007744|PDB:3SS5"
FT   SITE            72..73
FT                   /note="Cleavage; by MPP"
FT                   /evidence="ECO:0000250|UniProtKB:P13264"
FT   MOD_RES         135
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         169
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         316
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O94925"
FT   MOD_RES         657
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13264"
FT   VAR_SEQ         556..674
FT                   /note="VKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVV
FT                   KFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDDGKGNQTV
FT                   HKNLDGLL -> HSFGPLDYESLQQELALKDTVWKKVSPESSDDTSTTVVYRMESLGER
FT                   S (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15368895"
FT                   /id="VSP_043804"
FT   MUTAGEN         202
FT                   /note="K->E: Increased stimulation of enzyme activity by
FT                   phosphate."
FT                   /evidence="ECO:0000269|PubMed:23935106"
FT   MUTAGEN         207
FT                   /note="K->E: Increased stimulation of enzyme activity by
FT                   phosphate."
FT                   /evidence="ECO:0000269|PubMed:23935106"
FT   MUTAGEN         254
FT                   /note="Y->F: Increased enzyme activity in the absence of
FT                   phosphate. No effect on stimulation of enzyme activity by
FT                   phosphate."
FT                   /evidence="ECO:0000269|PubMed:27542409"
FT   MUTAGEN         316
FT                   /note="K->Q: Forms dimers with full, phosphate-independent
FT                   activity; when associated with A-325 and K-391."
FT                   /evidence="ECO:0000269|PubMed:27542409"
FT   MUTAGEN         320
FT                   /note="G->P: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:27542409"
FT   MUTAGEN         325
FT                   /note="K->A: Constitutive enzyme activity that is fully
FT                   active also in the absence phosphate. Forms oligomers with
FT                   full, phosphate-independent activity; when associated with
FT                   K-391. Forms dimers with full, phosphate-independent
FT                   activity; when associated with Q-316 and K-391."
FT                   /evidence="ECO:0000269|PubMed:23935106,
FT                   ECO:0000269|PubMed:27542409"
FT   MUTAGEN         391
FT                   /note="D->K: Abolishes assembly of dimers into functional
FT                   tetramers. Loss of enzyme activity. Forms oligomers with
FT                   full, phosphate-independent activity; when associated with
FT                   A-325. Forms dimers with full, phosphate-independent
FT                   activity; when associated with Q-316 and A-325."
FT                   /evidence="ECO:0000269|PubMed:27542409"
FT   MUTAGEN         394
FT                   /note="F->S: Impairs tetramerization and promotes formation
FT                   of homodimers. Impairs activation by phosphate."
FT                   /evidence="ECO:0000269|PubMed:22228304"
FT   HELIX           145..151
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          157..160
FT                   /evidence="ECO:0007744|PDB:3SS5"
FT   HELIX           161..170
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           178..180
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           181..193
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          194..200
FT                   /evidence="ECO:0007744|PDB:5W2J"
FT   HELIX           202..209
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           210..212
FT                   /evidence="ECO:0007744|PDB:5W2J"
FT   HELIX           213..220
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          224..227
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           229..243
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          249..251
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           256..259
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          267..272
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          277..282
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           290..293
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           294..313
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          321..328
FT                   /evidence="ECO:0007744|PDB:4JKT"
FT   STRAND          332..335
FT                   /evidence="ECO:0007744|PDB:3SS5"
FT   HELIX           340..349
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   TURN            350..353
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           356..370
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   TURN            371..373
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          376..378
FT                   /evidence="ECO:0007744|PDB:4JKT"
FT   HELIX           380..388
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           391..402
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           412..423
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          425..427
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           429..440
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   TURN            441..443
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   TURN            446..448
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           455..468
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           471..473
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   HELIX           474..480
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          485..487
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          491..497
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   TURN            498..500
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          501..506
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          508..510
FT                   /evidence="ECO:0007744|PDB:3SS3"
FT   STRAND          514..516
FT                   /evidence="ECO:0007744|PDB:3SS5"
FT   HELIX           517..529
FT                   /evidence="ECO:0007744|PDB:3SS3"
SQ   SEQUENCE   674 AA;  73964 MW;  C46824C83E1D9639 CRC64;
     MMRLRGSAML RELLLRPPAA VGAVLRRAQP LGTLCRRPRG GSRPTAGLVA AARLHPWWGG
     GGRAKGPGAG GLSSSPSEIL QELGKGGTPP QQQQQQQQQP GASPPAAPGP KDSPGETDAF
     GNSEGKEMVA AGDNKIKQGL LPSLEDLLFY TIAEGQEKIP VHKFITALKS TGLRTSDPRL
     KECMDMLRLT LQTTSDGVML DKDLFKKCVQ SNIVLLTQAF RRKFVIPDFM SFTSHIDELY
     ESAKKQSGGK VADYIPQLAK FSPDLWGVSV CTVDGQRHSI GDTKVPFCLQ SCVKPLKYAI
     AVNDLGTEYV HRYVGKEPSG LRFNKLFLNE DDKPHNPMVN AGAIVVTSLI KQGVNNAEKF
     DYVMQFLNKM AGNEYVGFSN ATFQSERESG DRNFAIGYYL KEKKCFPEGT DMVGILDFYF
     QLCSIEVTCE SASVMAATLA NGGFCPITGE RVLSPEAVRN TLSLMHSCGM YDFSGQFAFH
     VGLPAKSGVA GGILLVVPNV MGMMCWSPPL DKMGNSVKGI HFCHDLVSLC NFHNYDNLRH
     FAKKLDPRRE GGDQRVKSVI NLLFAAYTGD VSALRRFALS AMDMEQRDYD SRTALHVAAA
     EGHVEVVKFL LEACKVNPFP KDRWNNTPMD EALHFGHHDV FKILQEYQVQ YTPQGDSDDG
     KGNQTVHKNL DGLL
//
